Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from panax or acanthopanax
Reexamination Certificate
2007-06-26
2007-06-26
Leith, Patricia (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from panax or acanthopanax
C424S725000
Reexamination Certificate
active
10070209
ABSTRACT:
The present invention provides medicinal or pharmaceutical compositions and preparations for administration, which are useful as cytoprotective agents and a remedy for neurotrauma, comprising ginseng, its extract, ginseng components, metabolites thereof or salts thereof (for example, red ginseng powder or components thereof). More particularly, the present invention provides medicinal or pharmaceutical compositions for inhibiting apoptosis or apoptosis-like cell death, medicinal or pharmaceutical compositions for promoting the expression of a cell death-suppressing gene product Bcl-xL, or preparations for oral or intravenous administration, comprising ginseng, its extracts, ginseng components, metabolites thereof or salts thereof preferably at low concentrations. These medicinal or pharmaceutical compositions and/or preparations for administration are characterized by containing, as the active ingredient(s), ginseng, its extracts, ginseng components, metabolites thereof or salts thereof at low concentrations. These drugs are useful for therapy, prevention or treatment of brain and nervous diseases, heart diseases, etc.
REFERENCES:
patent: 4966893 (1990-10-01), Pang et al.
patent: 1 170 012 (2002-01-01), None
patent: 2648046 (1990-12-01), None
patent: 02 152926 (1990-06-01), None
patent: 4-504414 (1992-08-01), None
patent: 6-316527 (1994-11-01), None
patent: 2000-159793 (2000-06-01), None
patent: WO 99/09837 (1999-03-01), None
patent: WO 00/04912 (2000-02-01), None
Sakanaka et al. Ginseng Root's Ability to Prevent Learning Disability and Neuronal Loss in Normothermic Gerbils With 5-Min Forebrain Ischemia; Jpn. J. PHarmacol. (1995) 67, Suppl. I, 299P (One page English Abstract provided).
Masahiro, H. Preventive Effects of a Medicinal Carrot Component on Nerve Cell Death and Learning Behavior Disorder After Cerebral Ischemia; Mod. Phys. (1995) vol. 15, No. 3, pp. 384-388 (One page English Abstract provided).
Tamiko et al. Clinical Studies of Red Ginseng Powder on Cerebrovascular Disease; Wakan Iyakugaku Zasshi (Journal of Traditional Medicines) (1994) vol. 11, No. 4, pp. 352-353 (One page English Abstract provided).
Lin et al., “Transformation of ginsenosides Rg1 and Rb1, and crude Sanchi saponins by human intestinal microflora,”Journal of the Chinese Chemical Society48(1) (2001) (Abstract Only) Database Accession No. 2001:204459. (XP-002276421).
Zhang et al, “Influences of ginsenosides Rb1and Rg1on reversible focal brain ischemia in rats,”Acta Pharmacologica Sinica17:1 pp. 44-48 (1996). (XP002926090).
Sakanaka et al. “Ginseng Root's Ability to Prevent Learning Diability and Neuronal Loss in Normothermic Gerbils with 5-min Forebrain Ischemia,”Japanese Journal of Pharmacology67:1 (1995) (Abstract Only) (XP-001059689).
Gong et al., “Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development,”Trends in Pharmacological Sciences, Elsevier Trends Journal20(5):pp. 191-196 (1999).
Database WPI, Section Ch, Week 199725Derwent Publications Ltd.(Abstract Only) (XP-002276423).
Choi et al., “Inhibitory Effects ofPanax ginsengSaponin Fractions on Dexamethasone-induced Thymus Apoptosis,”Symposium on Current Topics in Pharmacology and Toxicology Catholic Research Institutes of Medical Sciencepp. 162 (1997) (Abstract Only) (XP-001180904).
Kim et al., “Panax ginsengblocks morphine-induced thymic apoptosis by lowering plasma corticosterone level,”General Pharmacology32(6):647-652 (1999).
Chen et al., “Cardiovascular Protection by Ginsenosides and Their Nitric Oxide Releasing Action,”Clinical and Experimental Pharmacology and Physiology23:728-732 (1996).
Gonzalez-Garcia et al., “bcl-xis expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death,”Proc. Natl. Acad. Sci USA92:4304-4308 (1995).
Wen et al., “Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischemia,” Acta Neuropathol. 91:15-22 (1996).
Kim Young, “Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration,” Database Biosis Accession No. PREV199800408338 (Abstract).
Li et al., “Study on the Anit-Apoptotic Mechanism of Ginsenoside Rg1 In Cultured Cortical Neurons,”Acta Pharmaceutica Sinica, 32(6):406-410 (1997).
Kim et al., “Radioprotective Effect of Red Ginseng in Irradiated Mice with High and Low Dose of Radiation,”Korean J. Ginseng Sci., 22(1):66-72 (1998).
Zhang et al., “Influences of ginsenosides Rb1and Rg1on reversible focal brain ischemia in rats,”Acta Pharmaceutica Sinica, 17(1):44-48 (1996).
Lim et al., “Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root,”Neuroscience Research, 28:191-200 (1997).
Liu et al., “Protective Effects of Ginsenoside Rb1and Rg1on Cultured Hippocampal Neurons,”Acta Pharmaceutica Sinica, 30(9):674-678 (1995).
Zhang et al., “Protective effects of total saponins ofPanax ginsengon ischemia-reperfusion injury in rat brains,”Chinese Journal of Pharmacology an Toxicology, 8(1):7-12 (1994).
Chu et al., “Protective effect of ginsenosides on acute cerebral ischemia/reperfusion injury of rats,”Chinese Journal of Pharmacology and Toxicology, 3(1):18-23 (1989).
Jiang er al., “Influences of ginsenosides Rb1, Rg2, and Rb3on electric and contractile activities of normal and damages cultured myocadiocytes,”Acta Pharmaceutica Sinica, 13(5):403-406 (1992).
Li et al., “Effects of berbamine on isolated myocardium in guinea pigs and humans,”Acta Pharmaceutica Sinica, 7(3)222-226 (1986).
Chen, “Cardiovascular Protection by Ginsenosides and Their Nitric Oxide Releasing Action,”Clinical and Experimental Pharmacology and Physiology, 23:728-732 (1996).
Li et al., “The Protective Effect of Ginsenosides and its Components on Myocytes Anoxia/Reoxygenation and Myocardial Reperfusion Injury,”Acta Pharmaceutica Sinica, 22(1):1-5 (1987).
Kondo et al., “Studies on the Constituents of Himalayan Ginseng,Panax pseudoginseng. I. The Structures of the Saponins,”Chemical and Pharmaceutical Bulletin, 21(13):2702-2711 (1973).
Kanaoka et al., “Studies on the Enzyme Immunoassay of Bio-active Constituents in Oriental Medicinal drugs. VI. Enzyme Immunoassay of Ginsenoside Rb1fromPanax ginseng,” Chemical and Pharmaceutical Bulletin, 40(2):314-317 (1992).
Maeda Nobuji
Nakata Kimihiko
Sakanaka Masahiro
Tanaka Junya
Butler, Esq. Gregory B.
Corless, Esq. Peter F.
Edwards Angell Palmer & & Dodge LLP
Japan Science and Technology Corporation
Leith Patricia
LandOfFree
Brain cell or nerve cell-protecting agents comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Brain cell or nerve cell-protecting agents comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Brain cell or nerve cell-protecting agents comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3865931